The top 12 most amazing Israeli medical advances
Israel is a powerhouse in medical innovation. We’ve chosen a dozen standouts from a field with many game-changing candidates.
Israel is a powerhouse in medical innovation. We’ve chosen a dozen standouts from a field with many game-changing candidates.
MeMed enables better informed antibiotic treatment decisions, an essential tool in the fight against the global threat of resistant bacteria.
Predictions announced at virtual OurCrowd Pandemic Innovation Conference attended by investors, entrepreneurs, executives, officials from 90 nations.
MeMed’s machine-learning technology employed to help physicians improve risk stratification, diagnosis, prognosis and monitoring of Covid patients.
Two Israeli startups and an Israeli university are ramping up solutions that may offer long-term help in dealing with the coronavirus epidemic.
MeMed wins European Innovation Council grant to accelerate launch of point-of-care platform that distinguishes between bacterial and viral infections.
Sisense is a popular business intelligence platform, and MeMed is a diagnostic system to distinguish bacterial from viral infections at point of care.
Cybersecurity, fintech, biomed, robotics, software, AI and AR companies received investments this month.
Antibiotic resistance is one of the world’s most serious health threats. Here’s how Israeli scientists are trying to overcome the problem.
Funds will be used to complete the development of first-ever point-of-care platform to distinguish bacterial from viral infections, within 15 minutes.
‘Lancet Infectious Diseases’ publishes study validating ImmunoXpert test’s ability to distinguish between bacterial and viral infections in children.
Israeli company MeMed has a rapid diagnostic kit for bacterial infections that could help revolutionize the fight against drug-resistant bacteria.